Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Anne Mette Lund Würtz
  • Anne Tjønneland
  • Jane Hvarregaard Christensen
  • Dragsted, Lars Ove
  • Julie Aarestrup
  • Cecilie Kyrø
  • Kim Overvad
  • Anja Olsen
Levels of endogenous estrogen and SHBG are associated with risk of breast cancer among women who have never used hormone replacement therapy (HRT). We investigated these associations in both never and baseline users of HRT.
OriginalsprogEngelsk
TidsskriftCancer Causes & Control
Vol/bind23
Udgave nummer10
Sider (fra-til)1711-1720
Antal sider10
ISSN0957-5243
DOI
StatusUdgivet - 2012

Bibliografisk note

IHE 2012 071

ID: 44648037